Rhythm Biosciences goes out of tune

Cancer test developer Rhythm Biosciences’ shares plunged on the ASX yesterday when the company withdrew an application for registration with the Therapeutic Goods Administration of its ColoSTAT test for colorectal cancer. The company’s shares closed down 38 percent to 36.5 cents last night after the company announced its response to its application for an Australian…

Manufacturing news briefs – stories you might have missed

Universal Biosensors appoints French distributor Electrochemical test developer Universal Biosensors has signed Vivelys SAS (France), part of the Oeneo Group, to be its French distributor for the company’s Sentia wine testing platform device. Vivelys will be non-exclusive distributor for a three year term for Sentia, which tests wine for sulphur dioxide, glucose, malic acid and…

Manufacturing news briefs – stories you might have missed

DroneShield sells to Australian army, receives US infrastructure order Drone detection and countermeasure company DroneShield has has sold a quantity of its RfOne MKIITM long-range sensors to the Australian Army (pictured). The capability is being delivered immediately to allow the Australian Army to assess its future counter-drone requirements and options. The company has also received…